Want to see DOCS full AI Analyst Report?

Doximity (DOCS) Stock Forecast & Price Target

1,028 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

DOCS Analyst Ratings

Moderate Buy

8 Buy

7 Hold

2 Sell

Based on 17 analysts giving stock ratings to

Doximity

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

DOCS Stock 12 Month Forecast

Average Price Target

$30.31

▲(48.45% Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Doximity in the last 3 months. The average price target is $30.31 with a high forecast of $47.00 and a low forecast of $18.00. The average price target represents a 48.45% change from the last price of $20.42.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","44":"$44","71":"$71","30.5":"$30.5","57.5":"$57.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$47.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.3125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,30.5,44,57.5,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.91,22.916923076923077,24.923846153846153,26.93076923076923,28.93769230769231,30.944615384615382,32.95153846153846,34.958461538461535,36.965384615384615,38.972307692307695,40.97923076923077,42.98615384615384,44.99307692307693,{"y":47,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.91,21.63326923076923,22.356538461538463,23.079807692307693,23.803076923076922,24.526346153846156,25.249615384615385,25.972884615384615,26.696153846153848,27.419423076923078,28.142692307692307,28.86596153846154,29.58923076923077,{"y":30.3125,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.91,20.686153846153847,20.462307692307693,20.23846153846154,20.014615384615386,19.790769230769232,19.566923076923075,19.34307692307692,19.119230769230768,18.895384615384614,18.67153846153846,18.447692307692307,18.223846153846154,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":57.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.64,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.07,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.28,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.29,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.93,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.98,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.55,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.59,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.91,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$47.00

Average Price Target$30.31

Lowest Price Target$18.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jailendra Singh

Truist Financial

$19→$24

Hold

17.53%

Upside

Reiterated

08/13/26

Truist Financial Remains a Hold on Doximity (DOCS)

Craig Hettenbach

Morgan Stanley

$35

Buy

71.40%

Upside

Reiterated

08/11/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Valiquette

Mizuho Securities

$26→$28

Hold

37.12%

Upside

Reiterated

08/11/26

Mizuho Securities Sticks to Their Hold Rating for Doximity (DOCS)

Alexei Gogolev

J.P. Morgan

$26→$31

Hold

51.81%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Their Hold Rating for Doximity (DOCS)

Stan Berenshteyn

Wells Fargo

$18

Sell

-11.85%

Downside

Downgraded

08/10/26

Doximity downgraded to Underweight from Equal Weight at Wells FargoDoximity downgraded to Underweight from Equal Weight at Wells Fargo

Allen Lutz

Bank of America Securities

$20

Sell

-2.06%

Downside

Reiterated

08/07/26

Analyst Reiterates Sell on Doximity Amid AI Investment Headwinds and Margin Pressure; $20 Price Target Unchanged

Richard Close

Canaccord Genuity

$30→$36

Buy

76.30%

Upside

Assigned

08/07/26

Doximity price target raised to $36 from $30 at CanaccordDoximity price target raised to $36 from $30 at Canaccord

Brian Peterson

Raymond James

$23→$38

Buy

86.09%

Upside

Reiterated

08/07/26

Doximity price target raised to $38 from $23 at Raymond JamesDoximity price target raised to $38 from $23 at Raymond James

Elizabeth Anderson CFA

Evercore ISI

$22→$40

Hold

95.89%

Upside

Reiterated

08/07/26

Doximity price target raised to $40 from $22 at Evercore ISIDoximity price target raised to $40 from $22 at Evercore ISI

Glen Santangelo

Barclays

$20

Hold

-2.06%

Downside

Reiterated

08/07/26

Doximity (DOCS) Gets a Hold from Barclays

Jessica Tassan

Piper Sandler

$42→$47

Buy

130.17%

Upside

Reiterated

08/07/26

Doximity (DOCS) Receives a Buy from Piper Sandler

Scott Berg

Needham

$27→$41

Buy

100.78%

Upside

Reiterated

08/07/26

Doximity (DOCS) Receives a Buy from Needham

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/06/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ryan Halsted

RBC Capital

$28

Buy

37.12%

Upside

Reiterated

08/06/26

Doximity (DOCS) Receives a Buy from RBC Capital

Sean Dodge

BMO Capital

$20→$30

Hold

46.91%

Upside

Assigned

08/06/26

Doximity price target raised to $30 from $20 at BMO CapitalDoximity price target raised to $30 from $20 at BMO Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jailendra Singh

Truist Financial

$19→$24

Hold

17.53%

Upside

Reiterated

08/13/26

Truist Financial Remains a Hold on Doximity (DOCS)

Craig Hettenbach

Morgan Stanley

$35

Buy

71.40%

Upside

Reiterated

08/11/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Valiquette

Mizuho Securities

$26→$28

Hold

37.12%

Upside

Reiterated

08/11/26

Mizuho Securities Sticks to Their Hold Rating for Doximity (DOCS)

Alexei Gogolev

J.P. Morgan

$26→$31

Hold

51.81%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Their Hold Rating for Doximity (DOCS)

Stan Berenshteyn

Wells Fargo

$18

Sell

-11.85%

Downside

Downgraded

08/10/26

Doximity downgraded to Underweight from Equal Weight at Wells FargoDoximity downgraded to Underweight from Equal Weight at Wells Fargo

Allen Lutz

Bank of America Securities

$20

Sell

-2.06%

Downside

Reiterated

08/07/26

Analyst Reiterates Sell on Doximity Amid AI Investment Headwinds and Margin Pressure; $20 Price Target Unchanged

Richard Close

Canaccord Genuity

$30→$36

Buy

76.30%

Upside

Assigned

08/07/26

Doximity price target raised to $36 from $30 at CanaccordDoximity price target raised to $36 from $30 at Canaccord

Brian Peterson

Raymond James

$23→$38

Buy

86.09%

Upside

Reiterated

08/07/26

Doximity price target raised to $38 from $23 at Raymond JamesDoximity price target raised to $38 from $23 at Raymond James

Elizabeth Anderson CFA

Evercore ISI

$22→$40

Hold

95.89%

Upside

Reiterated

08/07/26

Doximity price target raised to $40 from $22 at Evercore ISIDoximity price target raised to $40 from $22 at Evercore ISI

Glen Santangelo

Barclays

$20

Hold

-2.06%

Downside

Reiterated

08/07/26

Doximity (DOCS) Gets a Hold from Barclays

Jessica Tassan

Piper Sandler

$42→$47

Buy

130.17%

Upside

Reiterated

08/07/26

Doximity (DOCS) Receives a Buy from Piper Sandler

Scott Berg

Needham

$27→$41

Buy

100.78%

Upside

Reiterated

08/07/26

Doximity (DOCS) Receives a Buy from Needham

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/06/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ryan Halsted

RBC Capital

$28

Buy

37.12%

Upside

Reiterated

08/06/26

Doximity (DOCS) Receives a Buy from RBC Capital

Sean Dodge

BMO Capital

$20→$30

Hold

46.91%

Upside

Assigned

08/06/26

Doximity price target raised to $30 from $20 at BMO CapitalDoximity price target raised to $30 from $20 at BMO Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Doximity

3 Months

Ryan DanielsWilliam Blair

Success Rate

6/9 ratings generated profit

Average Return

+10.90%

Copying Ryan Daniels's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +10.90% per trade.

1 Year

Richard CloseCanaccord Genuity

Success Rate

8/18 ratings generated profit

Average Return

+20.58%

Copying Richard Close's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +20.58% per trade.

2 Years

Richard CloseCanaccord Genuity

Success Rate

10/18 ratings generated profit

Average Return

+35.90%

Copying Richard Close's trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +35.90% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DOCS Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, DOCS has received 13 Buy Ratings, 13 Hold Ratings, and 5 Sell Ratings. DOCS average Analyst price target in the past 3 months is 30.31.

Each month's total comprises the sum of three months' worth of ratings.

DOCS Financial Forecast

DOCS Earnings Forecast

Next quarter’s earnings estimate for DOCS is $0.34 with a range of $0.17 to $0.40. The previous quarter’s EPS was $0.29. DOCS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.

DOCS Sales Forecast

Next quarter’s sales forecast for DOCS is $170.45M with a range of $168.30M to $171.40M. The previous quarter’s sales results were $156.62M. DOCS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.

DOCS Stock Forecast FAQ

What is DOCS’s average 12-month price target, according to analysts?

Based on analyst ratings, Doximity, Inc.’s 12-month average price target is 30.31.

What is DOCS’s upside potential, based on the analysts’ average price target?

Doximity, Inc. has 48.45% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DOCS a Buy, Sell or Hold?

Doximity, Inc. has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 2 sell ratings.

What is Doximity, Inc.’s price target?

The average price target for Doximity, Inc. is 30.31. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $47.00 ,the lowest forecast is $18.00. The average price target represents 48.45% Increase from the current price of $20.42.

What do analysts say about Doximity, Inc.?

Doximity, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of DOCS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Doximity (DOCS) Stock Forecast & Price Target

DOCS Analyst Ratings

DOCS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Doximity

DOCS Analyst Recommendation Trends

DOCS Financial Forecast

DOCS Earnings Forecast

DOCS Sales Forecast

DOCS Stock Forecast FAQ

Detailed List of Analyst Forecasts